McKesson MCK
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
McKesson (MCK) Business Model and Operations Summary
McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Key Insights
McKesson (MCK) Core Market Data and Business Metrics
Latest Closing Price
$673.69Market Cap
$84.20 BillionPrice-Earnings Ratio
34.92Total Outstanding Shares
126.94 Million SharesTotal Employees
51,000Dividend
$0.71 Per Share QuarterlyIPO Date
August 3, 1987SIC Description
Wholesale-drugs, Proprietaries & Druggists' SundriesPrimary Exchange
New York Stock ExchangeHeadquarters
6555 State Highway 161, Irving, TX, 75039
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Exchange Gains/Losses | $8 Million |
| Net Cash Flow | $1 Million |
| Net Cash Flow From Operating Activities, Continuing | $5.12 Billion |
| Net Cash Flow From Investing Activities, Continuing | $-1.13 Billion |
| Net Cash Flow From Financing Activities, Continuing | $-4.00 Billion |
| Net Cash Flow From Financing Activities | $-4.00 Billion |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Operating Income/Loss | $3.46 Billion |
| Selling, General, and Administrative Expenses | $9.20 Billion |
| Income/Loss From Continuing Operations Before Tax | $3.40 Billion |
| Net Income/Loss Available To Common Stockholders, Basic | $2.54 Billion |
| Operating Expenses | $9.67 Billion |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
Comprehensive Income
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $171 Million |
| Other Comprehensive Income/Loss Attributable To Parent | $-3 Million |
| Other Comprehensive Income/Loss | $-3 Million |
| Comprehensive Income/Loss | $2.70 Billion |
| Comprehensive Income/Loss Attributable To Parent | $2.53 Billion |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Liabilities And Equity | $72.43 Billion |
| Accounts Payable | $53.32 Billion |
| Noncurrent Liabilities | $16.30 Billion |
| Long-term Debt | $5.74 Billion |
| Current Assets | $53.34 Billion |
| Equity | $-2.64 Billion |
Historical Dividends
Current dividend: $0.71 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Jan 30, 2025 | Apr 1, 2025 | Mar 3, 2025 | $0.71 | Quarterly |
| Oct 31, 2024 | Jan 2, 2025 | Dec 2, 2024 | $0.71 | Quarterly |
| Aug 1, 2024 | Oct 1, 2024 | Sep 2, 2024 | $0.71 | Quarterly |
| Apr 24, 2024 | Jul 1, 2024 | Jun 3, 2024 | $0.62 | Quarterly |
| Feb 1, 2024 | Apr 1, 2024 | Mar 1, 2024 | $0.62 | Quarterly |
| Oct 26, 2023 | Jan 2, 2024 | Dec 1, 2023 | $0.62 | Quarterly |